1. Home
  2. PBM vs CHEK Comparison

PBM vs CHEK Comparison

Compare PBM & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • CHEK
  • Stock Information
  • Founded
  • PBM 1994
  • CHEK 2004
  • Country
  • PBM Canada
  • CHEK Israel
  • Employees
  • PBM N/A
  • CHEK N/A
  • Industry
  • PBM
  • CHEK Medical Electronics
  • Sector
  • PBM
  • CHEK Health Care
  • Exchange
  • PBM NYSE
  • CHEK Nasdaq
  • Market Cap
  • PBM 5.3M
  • CHEK 4.5M
  • IPO Year
  • PBM N/A
  • CHEK 2015
  • Fundamental
  • Price
  • PBM $0.44
  • CHEK $0.66
  • Analyst Decision
  • PBM
  • CHEK
  • Analyst Count
  • PBM 0
  • CHEK 0
  • Target Price
  • PBM N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • PBM 110.0K
  • CHEK 56.3K
  • Earning Date
  • PBM 04-15-2025
  • CHEK 05-14-2025
  • Dividend Yield
  • PBM N/A
  • CHEK N/A
  • EPS Growth
  • PBM N/A
  • CHEK N/A
  • EPS
  • PBM N/A
  • CHEK N/A
  • Revenue
  • PBM N/A
  • CHEK N/A
  • Revenue This Year
  • PBM N/A
  • CHEK N/A
  • Revenue Next Year
  • PBM N/A
  • CHEK N/A
  • P/E Ratio
  • PBM N/A
  • CHEK N/A
  • Revenue Growth
  • PBM N/A
  • CHEK N/A
  • 52 Week Low
  • PBM $0.37
  • CHEK $0.56
  • 52 Week High
  • PBM $108.00
  • CHEK $3.04
  • Technical
  • Relative Strength Index (RSI)
  • PBM 20.99
  • CHEK 35.52
  • Support Level
  • PBM $0.37
  • CHEK $0.77
  • Resistance Level
  • PBM $0.70
  • CHEK $0.86
  • Average True Range (ATR)
  • PBM 0.07
  • CHEK 0.08
  • MACD
  • PBM 0.01
  • CHEK -0.01
  • Stochastic Oscillator
  • PBM 20.22
  • CHEK 16.41

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: